Optimization and Evaluation of the In Vitro Permeation Parameters of Topical Products with Non-Steroidal Anti-Inflammatory Drugs Through Strat-M Membrane

Overview

Journal Pharmaceutics

Publisher MDPI

Date 2021 Aug 28

PMID 34452264

Citations 10

Authors

Bartlomiej Milanowski

Hanna Wosicka-Frackowiak

Eliza Glowka

Malgorzata Sosnowska

Stanislaw Wozny

Filip Stachowiak

Angelika Suchenek

Dariusz Wilkowski

Affiliations

Soon will be listed here.

Abstract

Pharmaceutical products containing non-steroidal anti-inflammatory drugs (NSAIDs) are among the most prescribed topical formulations used for analgesic and antirheumatic properties. These drugs must overcome the skin barrier to cause a therapeutic effect. Human skin has been widely used as a model to study in vitro drug diffusion and permeation, however, it suffers from many limitations. Therefore, to perform in vitro permeation test (IVPT), we used a Strat-M membrane with diffusion characteristics well-correlated to human skin. This study's objective was to optimize the IVPT conditions using Plackett-Burman experimental design for bio-predictive evaluation of the in vitro permeation rates of five non-steroidal anti-inflammatory drugs (diclofenac, etofenamate, ibuprofen, ketoprofen, naproxen) across Strat-M membrane from commercial topical formulations. The Plackett-Burman factorial design was used to screen the effect of seven factors in eight runs with one additional center point. This tool allowed us to set the sensitive and discriminative IVPT final conditions that can appropriately characterize the NSAIDs formulations. The permeation rate of etofenamate (ETF) across the Strat-M membrane was 1.7-14.8 times faster than other NSAIDs from selected semisolids but 1.6 times slower than the ETF spray formulation.

Citing Articles

Highly Biocompatible Lamellar Liquid Crystals Based on Hempseed or Flaxseed Oil with Incorporated Betamethasone Dipropionate: A Bioinspired Multi-Target Dermal Drug Delivery System for Atopic Dermatitis Treatment.

Vitek M, Medos Z, Lavric Z, Jeras M, Planinsek O, Zvonar Pobirk A Int J Nanomedicine. 2024; 19:13687-13715.

PMID: 39723176 PMC: 11669336. DOI: 10.2147/IJN.S488684.

Molybdenum Disulfide Nanosheet-Based Nanocomposite for the Topical Delivery of Umbelliferone: Evaluation of Anti-inflammatory and Analgesic Potentials.

Lal D, Kumar B, Kaushik V, Alhowyan A, Kalam M ACS Omega. 2024; 9(35):37105-37116.

PMID: 39246492 PMC: 11375718. DOI: 10.1021/acsomega.4c04252.

Exploring Microemulsion Systems for the Incorporation of Glucocorticoids into Bacterial Cellulose: A Novel Approach for Anti-Inflammatory Wound Dressings.

Zahel P, Bruggink V, Hulsmann J, Steiniger F, Hofstetter R, Heinzel T Pharmaceutics. 2024; 16(4).

PMID: 38675165 PMC: 11054342. DOI: 10.3390/pharmaceutics16040504.

Enhanced Skin Permeation of 5-Fluorouracil through Drug-in-Adhesive Topical Patches.

Kim S, Youssef S, Lee K, Song Y, Vaidya S, Garg S Pharmaceutics. 2024; 16(3).

PMID: 38543273 PMC: 10975131. DOI: 10.3390/pharmaceutics16030379.

Hydrogel Formulations for Topical Insulin Application: Preparation, Characterization and In Vitro Permeation across the Strat-M Membrane.

Ostrozka-Cieslik A, Wilczynski S, Dolinska B Polymers (Basel). 2023; 15(17).

PMID: 37688265 PMC: 10489751. DOI: 10.3390/polym15173639.

References

Marinho O, Pereira A . Clinical Efficacy and Safety Profile of Topical Etofenamate in the Treatment of Patients with Musculoskeletal Disorders: A Systematic Review. Pain Ther. 2020; 9(2):393-410. PMC: 7648768. DOI: 10.1007/s40122-020-00177-1. View

Minghetti P, Cilurzo F, Casiraghi A, Montanari L, Fini A . Ex vivo study of transdermal permeation of four diclofenac salts from different vehicles. J Pharm Sci. 2007; 96(4):814-23. DOI: 10.1002/jps.20770. View

Uchida T, Kadhum W, Kanai S, Todo H, Oshizaka T, Sugibayashi K . Prediction of skin permeation by chemical compounds using the artificial membrane, Strat-M™. Eur J Pharm Sci. 2014; 67:113-118. DOI: 10.1016/j.ejps.2014.11.002. View

Kopecna M, Kovacik A, Novak P, Boncheva Bettex M, Vavrova K . Transdermal Permeation and Skin Retention of Diclofenac and Etofenamate/Flufenamic Acid From Over-the-Counter Pain Relief Products. J Pharm Sci. 2021; 110(6):2517-2523. DOI: 10.1016/j.xphs.2021.01.022. View

Trauer S, Richter H, Kuntsche J, Buttemeyer R, Liebsch M, Linscheid M . Influence of massage and occlusion on the ex vivo skin penetration of rigid liposomes and invasomes. Eur J Pharm Biopharm. 2013; 86(2):301-6. DOI: 10.1016/j.ejpb.2013.11.004. View

Dancik Y, Kichou H, Eklouh-Molinier C, Souce M, Munnier E, Chourpa I . Freezing Weakens the Barrier Function of Reconstructed Human Epidermis as Evidenced by Raman Spectroscopy and Percutaneous Permeation. Pharmaceutics. 2020; 12(11). PMC: 7694161. DOI: 10.3390/pharmaceutics12111041. View

Schmook F, Meingassner J, Billich A . Comparison of human skin or epidermis models with human and animal skin in in-vitro percutaneous absorption. Int J Pharm. 2001; 215(1-2):51-6. DOI: 10.1016/s0378-5173(00)00665-7. View

Pradal J, Vallet C, Frappin G, Bariguian F, Lombardi M . Importance of the formulation in the skin delivery of topical diclofenac: not all topical diclofenac formulations are the same. J Pain Res. 2019; 12:1149-1154. PMC: 6489664. DOI: 10.2147/JPR.S191300. View

Bhattacharya S, Banerjee S, Ghosh A, Chattopadhyay P, Verma A, Ghosh A . A RP-HPLC method for quantification of diclofenac sodium released from biological macromolecules. Int J Biol Macromol. 2013; 58:354-9. DOI: 10.1016/j.ijbiomac.2013.03.065. View

10.

Rannou F, Pelletier J, Martel-Pelletier J . Efficacy and safety of topical NSAIDs in the management of osteoarthritis: Evidence from real-life setting trials and surveys. Semin Arthritis Rheum. 2016; 45(4 Suppl):S18-21. DOI: 10.1016/j.semarthrit.2015.11.007. View

11.

Sacha M, Faucon L, Hamon E, Ly I, Haltner-Ukomadu E . Ex vivo transdermal absorption of a liposome formulation of diclofenac. Biomed Pharmacother. 2019; 111:785-790. DOI: 10.1016/j.biopha.2018.12.079. View

12.

Hadgraft J, WHITEFIELD M, Rosher P . Skin penetration of topical formulations of ibuprofen 5%: an in vitro comparative study. Skin Pharmacol Appl Skin Physiol. 2003; 16(3):137-42. DOI: 10.1159/000069759. View

13.

Mohamed L, Kamal N, Elfakhri K, Ibrahim S, Ashraf M, Zidan A . Application of synthetic membranes in establishing bio-predictive IVPT for testosterone transdermal gel. Int J Pharm. 2020; 586:119572. DOI: 10.1016/j.ijpharm.2020.119572. View

14.

Haq A, Dorrani M, Goodyear B, Joshi V, Michniak-Kohn B . Membrane properties for permeability testing: Skin versus synthetic membranes. Int J Pharm. 2018; 539(1-2):58-64. DOI: 10.1016/j.ijpharm.2018.01.029. View

15.

Thomas S, Shin S, Hammell D, Hassan H, Stinchcomb A . Effect of Controlled Heat Application on Topical Diclofenac Formulations Evaluated by In Vitro Permeation Tests (IVPT) Using Porcine and Human Skin. Pharm Res. 2020; 37(3):49. DOI: 10.1007/s11095-019-2741-1. View

16.

Zhang Y, Huo M, Zhou J, Zou A, Li W, Yao C . DDSolver: an add-in program for modeling and comparison of drug dissolution profiles. AAPS J. 2010; 12(3):263-71. PMC: 2895453. DOI: 10.1208/s12248-010-9185-1. View

17.

Pradal J . Comparison of Skin Permeation and Putative Anti-Inflammatory Activity of Commercially Available Topical Products Containing Ibuprofen and Diclofenac. J Pain Res. 2020; 13:2805-2814. PMC: 7650811. DOI: 10.2147/JPR.S262390. View

18.

Sanna V, Peana A, Moretti M . Effect of vehicle on diclofenac sodium permeation from new topical formulations: in vitro and in vivo studies. Curr Drug Deliv. 2009; 6(1):93-100. DOI: 10.2174/156720109787048311. View

19.

Peraman R, Nayakanti D, Dugga H, Kodikonda S . Development and Validation of a Stability-Indicating Assay of Etofenamate by RP-HPLC and Characterization of Degradation Products. Sci Pharm. 2014; 81(4):1017-28. PMC: 3867237. DOI: 10.3797/scipharm.1305-19. View

20.

Takahashi K, Sakano H, Numata N, Kuroda S, Mizuno N . Effect of fatty acid diesters on permeation of anti-inflammatory drugs through rat skin. Drug Dev Ind Pharm. 2002; 28(10):1285-94. DOI: 10.1081/ddc-120015362. View